FDA Drug Application (020818) for DIOVAN HCT by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020818
Product Number001
FormTABLET;ORAL
Dosage12.5MG;80MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIOVAN HCT
Active IngredientHYDROCHLOROTHIAZIDE; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by NOVARTIS